Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0376544
Disease: Hematopoietic Neoplasms
Hematopoietic Neoplasms
0.020 Biomarker group BEFREE We conclude that Syk constitutes a key regulator of B-CLL cell survival, emphasizing the clinical utility of Syk inhibition in hematopoietic malignancies. 19581935 2009
CUI: C0376544
Disease: Hematopoietic Neoplasms
Hematopoietic Neoplasms
0.020 Biomarker group BEFREE These data implicate that the rearranged Syk gene is involved in the pathogenesis of hematopoietic malignancies. 11159536 2001